Results 21 to 30 of about 29,788 (124)

Targetable IDH1 mutation identified in a rare case of pancreatic serous cystadenocarcinoma but not a series of serous cystadenomas. [PDF]

, 2022
Serous cystadenocarcinoma (SCAC) of the pancreas is rare, with only 35 cases reported in the literature. We present a case of SCAC, comparing the clinical presentation, management and molecular features of this case to a series of serous cystadenoma (SCA)
Tran-Harding, Karen, Wang, Chi, Pandalai, Prakash, Wu, Yuanyuan, Kim, Joseph, Schaberg, Kurt, Nair, Rashmi, Hammonds, Autumn, Cavnar, Michael, Kolesar, Jill, Zhang, Yuxi, Jill Kolesar, Kurt B Schaberg, Michael J Cavnar, Yuanyuan Wu, Prakash K Pandalai, Karen Tran-Harding, Chi Wang, Yuxi Zhang, Autumn Hammonds, Joseph Kim, Rashmi T Nair   +21 more
core   +1 more source

Evaluation of the Potential Diagnostic Utility of the Determination of Selected Caspases—Markers Involved in the Regulation of Apoptosis—In Patients with Ovarian Cancer

Diagnostics, 2021
Ovarian cancer remains a major diagnostic and therapeutic problem in modern gynecological oncology. For this reason, research which focuses on the search for new diagnostic markers and the assessment of their possible usefulness in clinical practice is ...
Aleksandra Mielczarek-Palacz, Sylwia Jasińska, Anna Strzelec   +2 more
doaj   +1 more source

A rare case scenario of didelphic uterus with ovarian serous cystadenocarcinoma: an unusual clinical finding [PDF]

, 2023
Uterine didelphys in women is uncommon. The improper development of the Mullerian ducts during the intrauterine period leads to congenital abnormalities of the female genital system.
Varshney, Shivangi, Sharma, Gaurav, Sharma, Medhavi, Gaurav Sharma, Shivangi Varshney, Medhavi Sharma   +5 more
core   +1 more source

Benign macrocystic serous cystadenoma of the pancreas

Indian Journal of Pathology and Microbiology, 2021
Serous cystadenoma is a rare benign cystic lesion of pancreas. They are mostly known as benign cystic tumors of pancreas but malign transformation as serous cystadenocarcinoma is also reported.
Selma Erdogan Duzcu, Nur Tunc
doaj   +1 more source

Clinico-Histopathological Analysis of Neoplastic and Non-Neoplastic Lesions of the Ovary: A 3-Year Prospective Study in Dhule, North Maharashtra, India [PDF]

Journal of Clinical and Diagnostic Research, 2014
Background: Ovary is the commonest site of neoplastic and nonneoplastic lesion, can present in childhood to postmenopausal age group and accounts for the most prevalent cause of hospital admissions. Aim: This study was done to analyse the frequency of
Kanthikar S.N., Dravid N.V., Deore P.N., Nikumbh D.B., Suryawanshi K.H.   +4 more
doaj   +1 more source

Pancreatic Serous Cystadenocarcinoma: A Case Report and Review of the Literature [PDF]

, 2009
BackgroundSerous cystic neoplasms of the pancreas are benign lesions with little chance for malignant degeneration. We report a case of malignant serous cystadenocarcinoma of the pancreas and review the literature.MethodsStructured review of the ...
Stephen C. White, Howard A. Reber, O. Joe Hines, Reber, Howard A, Galen Cortina, Jonathan C. King, King, Jonathan C, Cortina, Galen, Tina T. Ng, Ng, Tina T, White, Stephen C, Hines, O Joe   +11 more
core   +1 more source

Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer—Participation in Pathogenesis or a Possible Clinical Use?

Cells, 2020
Due to the ability to selectively induce apoptosis in cancer cells, the most interesting target for clinical research is the tumour necrosis factor ligand inducing apoptosis (TRAIL), which binds specific receptors, including osteoprotegerin (OPG).
Aleksandra Mielczarek-Palacz, Zdzisława Kondera-Anasz, Marta Smycz-Kubańska   +2 more
doaj   +1 more source

CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress

BMC Cancer, 2019
Background Recent studies have found that inflammatory response is involved in the pathogenesis of ovarian cancer. Advanced ovarian cancer is often presented with ascites that is rich in cytokines, inflammatory factors or cancer cells.
Jun Shi, Rongfen Huo, Ningli Li, Haichuan Li, Tianhang Zhai, Huidan Li, Baihua Shen, Jing Ye, Ruojin Fu, Wen Di   +9 more
doaj   +1 more source

A rare case of collision tumor: Massive mucinous cystadenoma and benign mature cystic teratoma arising in the same ovary

CHRISMED Journal of Health and Research, 2017
Collision tumor means the coexistence of two adjacent, but histologically distinct tumors without histologic admixture in the same tissue and is rare incidence involving the ovary.
Reddy Ravikanth
doaj   +1 more source

Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer

Journal of Ovarian Research, 2019
Background The role of calcineurin/NFAT signaling in ovarian cancer has been unknown. NFAT was significantly overexpressed in ovarian cancer tissues and that overexpression of NFAT was significantly associated with metastasis and poor prognosis on ...
Bing Xin, Kai-Qiang Ji, Yi-Si Liu, Xiao-Dong Zhao   +3 more
doaj   +1 more source